FIELD: medicine.
SUBSTANCE: method involves administering immunity correction treatment. Wobenzyme is used as immunocorrecting agent at a dose of 7 tablets 3 times a day during 1 month and intramuscular 40 mg of Triamcinolon is additionally applied every other day. 0.1% Indocollir solution 1 drop three times a day combined with Vidisic 1 drop twice a day as are applied on the background of mentioned therapy course.
EFFECT: stable blood circulation normalization in retinal blood vessels; reduced proliferation process intensity.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ENDOCRINE OPHTHALMOPATHY TREATMENT | 2020 |
|
RU2725861C1 |
METHOD FOR DIAGNOSING OPTIC NERVE ABNORMALITY IN THE CASES OF ENDOCRINE OPHTHALMOPATHY | 2004 |
|
RU2262892C1 |
METHOD OF TREATING ENDOCRINE OPHTHALMOPATHY | 2012 |
|
RU2483723C1 |
METHOD OF COMBINED CONSERVATIVE TREATMENT OF ACTIVE ENDOCRINE OPHTHALMOPATHY | 2022 |
|
RU2806503C1 |
METHOD FOR THE TREATMENT OF OPTIC NEUROPATHY IN PATIENTS WITH EDEMATOUS EXOPHTHALMOS | 2020 |
|
RU2742188C1 |
METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
METHOD OF TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2006 |
|
RU2335283C2 |
METHOD FOR ENDOCRINE OPHTHALMOPATHY EARLIEST MANIFESTATIONS DIAGNOSING | 2016 |
|
RU2617198C1 |
METHOD FOR PREVENTING OPTIC NERVE ATROPHY IN CLOSED CRANIOCEREBRAL INJURY CASES | 2006 |
|
RU2315600C2 |
METHOD FOR TREATMENT OF GLAUCOMA DISCIRCULATORY VARIANT IN PATIENTS WITH MYOPIC REFRACTION | 2004 |
|
RU2281767C2 |
Authors
Dates
2008-01-10—Published
2006-07-13—Filed